Conception Biosciences
working to differentiate hiPSCs — including cells reprogrammed from blood samples — into early-stage human egg cells and mini-ovary structures, aiming to eliminate the age-related fertility barrier without a donor oocyte.
- Country
- United States
ivg
stem-cells
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| In-vitro gametogenesis (IVG) & reproductive synbio | regenerative-personalized | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.